$3,000,000.00 left in available cash would be a very optimistic guess (closer to $1M-2M might be more realistic). NNVC has around 70 million outstanding shares.
The Shelton facility could vanish or double in size overnight, and that wouldn't affect the valuation of the stock. There are similarly sized commercial spaces listed for sale in Shelton for well under $2M. Whatever inflated price they paid Diwan, it doesn't really add much, if anything, to the valuation.
NNVC's value is entirely based on the degree of belief in Diwan having discovered the Penicillin for viruses than can be developed into a mega-billion dollar.
This belief is largely based on ignorance or apathy by investors about the details of the Theracour deal that makes such an opportunity impossible. That's even if an unremarkable engineer without any knowledge of drug development really did discover the most important drug of the century on the back of a napkin.
Given the likelihood that the company will last only as long as their available cash, a fair value today might be closer to $0.04/share. That wouldn't include any discounts for either the overwhelming risk, or for the deals with Diwan that make failure a near certainty.
News 
Market Data 
Discover 
